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Abstract
The Myositis Activity Profile (MAP) is the only disease-specific questionnaire to assess limi-
tations in activities of daily living (ADL) in patients with inflammatory myopathy (IM).
Because a German version does not currently exist, this study’s aim was to translate the
MAP and assess reliability and construct validity of the new version. Therefore, a cross-cul-
tural adaptation was performed following international guidelines. Forty-eight patients with
IM completed the German-MAP, twice within two weeks. They were also assessed using
the Health Assessment Questionnaire (HAQ), 36-Item Short Form Survey (SF36), Manual
Muscle Test (MMT8), Quantitative Muscle Testing (QMT) and Functional Index (FI-2). For
discriminant validity, 48 age-and gender-matched healthy controls completed the German-
MAP. Reliability was assessed using weighted kappa (Kw). Correlations between the MAP
and the HAQ, the physical (PCM) and mental (MCS) component scores of SF36 and the
MMT8 and QMT muscle tests were assessed using Spearman correlation analysis. Discrim-
inative validity was assessed by calculating the Area under the Curve (AUC). The German-
MAP showed substantial reliability for the four subscales (Kw: 0.65–0.71) and moderate to
substantial reliability for the single items (Kw: 0.57–0.77). The MAP showed good construct
validity (high correlations with HAQ and PCM, moderate with FI-2, QMT and MMT8 and
poor with MCS and pain) and acceptable discrimination for three subscales and two single
items (AUC: 0.65–0.79). In conclusion, the German-MAP appears to be a reliable and valid
questionnaire to assess ADL-limitations in patients with IM. Further research is required,
both to substantiate these results and to evaluate responsiveness.
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Introduction
Inflammatory myopathies (IMs), including polymyositis (PM) and dermatomyositis (DM),
are chronic, idiopathic inflammatory muscle diseases characterized by decreased muscle
strength and endurance, general fatigue, and, in some cases, muscle pain and extra- muscular
manifestations such as lung fibrosis [1]. Epidemiological studies have reported widely varying
incidence rates between 0.1 and 7.89 cases per 100,000 annually [2–4]. Although relatively
rare, IMs pose a significant socioeconomic burden causing increased medical costs and
resource usage. Moreover, there is substantial disease morbidity [4, 5]. The most prominent
clinical features in all subcategories of IMs are proximal and (often) symmetric muscle weak-
ness and low muscle endurance, combined with progressive decline of functional performance
over a period of weeks or months. This results in significant difficulties in everyday tasks, such
as self-care or household chores, combined with limited community mobility [6, 7].
Until recently, activity limitation in patients with IM has been assessed with the Health
Assessment Questionnaire (HAQ). Arthritis-specific instruments such as the HAQ permit
comparisons between different rheumatologic diagnoses. However tools like this may be insuf-
ficiently sensitive to capture activity limitations caused by a specific non-arthritic condition
[8]. The Myositis Activity Profile (MAP) was the first disease-specific activity limitation ques-
tionnaire for use with patients who have IM. It was developed in Sweden and later translated
into the English language [8, 9]. Both the Swedish and English versions showed promising,
preliminary psychometric properties in patients with IM. The MAP correlated well with the
HAQ and showed fair-to-moderate correlation with muscle endurance (assessed with the
functional index in myositis) and muscle strength (assessed with the manual muscle test) [8,
9]. To date, correlations between the MAP and health-related quality of life (HRQL) and pain
have, to the best of our knowledge, not been determined. Because the MAP focusses on activity
limitation and correlates with muscle endurance and strength, it can be hypothesized that the
MAP tends rather to correlate with physical components of HRQL (e.g. with the physical com-
ponent of the SF36 questionnaire), than with those components reflecting mental and pain
aspects of life quality.
The MAP is based on the International Classification of Impairments, Disabilities and
Handicaps-2 (ICIDH) Beta-2 draft, an earlier version of the International Classification of
Functioning, Disability and Health (ICF). It includes 32 items, which are each answered on a
seven-point Likert scale; where one equals no difficulty to perform and seven equals impossible
to perform. These items are divided into four subscales (movement activities, activities of mov-
ing around, personal care, and domestic activities) and four single items (keeping in touch
with close friends and relatives, avoiding overexertion during daily activities, being able to
cope with work and/or housework to a satisfactory degree, and being able to do recreational
activities of choice). The four subscales are scored using the median value of item responses
within each, while the four single items are scored using the actual item response value. Addi-
tionally, a total median score across the four subscales and the four single items is also calcu-
lated [10]. Overall, the MAP assesses activity limitation within a broad perspective, meaning
that patients weight their difficulties against their needs when answering the questions [11].
To date and to the best of our knowledge, a German version of the MAP has not been devel-
oped. Therefore, the aim of this study was to translate and cross-culturally adapt the MAP into
German following international guidelines [12, 13], and then evaluate construct validity and
reliability of this new version. We hypothesized that the total median score across the four sub-
scales and the four single items of the German-MAP would correlate highly with the HAQ and
the physical component of the SF36, moderately with muscle function (strength and endur-
ance), but lower with pain and the mental component of the SF 36. Furthermore, we
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hypothesized acceptable discriminant validity, substantial reliability with no systematic varia-
tions between test and retest, no internal redundancy or poor internal consistency.
Material and methods
Participants
Patients with IM were recruited from the Department of Rheumatology at the University Hos-
pital Zurich. Inclusion criteria were diagnosis of PM, DM or associated myositis, age over 18,
and ability to read and understand German. Excluded were patients diagnosed with inclusion
body myositis, osteoporosis, severe cardiovascular and/or pulmonary disease, pain syndrome,
and paresis. To evaluate discriminative validity, a healthy control group individually matched
by age and gender was recruited. Healthy was defined as not having any disease diagnosed by a
medical doctor.
Cross-cultural translation
The cross-cultural translation into German was performed in four steps, in accordance with
international guidelines and with permission for translation from the original MAP developers
[12, 13]. In step 1, two independent investigators each independently translated the MAP from
English into German (T1 and T2). One of the translators was aware of the questionnaire con-
cept. The second step was the synthesis of these two German versions, achieved by consensus
discussion between the two translators. This produced a consensus German version (T1/2). In
the third step, T1/2 was independently translated backwards by two native English-speaking
persons, to produce two further English language versions (BT1 and BT2). Both persons were
unaware of the questionnaire concept and were unfamiliar with the original English question-
naire. In step four, all four translators discussed any discrepancies retrieved between the origi-
nal and the translated versions and produced a pre-final version. The understanding of this
pre-final version was tested in practice with three patients with IM, before a final German ver-
sion (S1 Appendix) was arrived at. This was then tested for validity and reliability.
Assessments
The HAQ consists of 20 questions divided into eight sections: dressing, rising, eating, walking,
hygiene, reaching, gripping objects, and performance of activities. Scoring within each section
varies from zero (without any difficulty) to three (unable to do) [14].
The SF-36 is a generic patient-reported outcome measure aimed at quantifying health-
related quality of life (HRQOL). The questionnaire includes 36 questions, divisible into a phys-
ical component summary (PCS) and a mental component summary (MCS). In both of these
components, higher scores indicate better HRQOL [15].
The Functional Index in Myositis (FI-2) is a disease-specific observational tool to measure
muscle endurance. The FI-2 measures the number of repetitions performed in seven muscle
groups/activities on the dominant side of the body. Each muscle group is scored by the num-
ber of correctly performed repetitions, ranging from 0–60 for shoulder flexion, shoulder
abduction, neck flexion, hip flexion, knee extension and step test, and from 0–120 for heel and
toe lifts. Sixty and 120 repetitions respectively indicate normal endurance [16]. To compute a
total percentage score for all performed repetitions, all individual muscle group scores are
summed and then divided by seven.
The MMT8 is a disease specific subset of eight proximal, distal, and axial muscle groups
tested unilaterally to measure muscle strength. Each muscle group is scored from 0–10 on the
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Kendall scale. Zero indicates no muscle contraction and ten equals normal strength. The
scores are summed up to a total score with a range varying from 0–80 [17].
Quantitative Muscles Testing (QMT) was performed with the microFET2. Maximum mus-
cle strength of each of the muscle groups included in the MMT8 (shoulder abduction, elbow
flexion, ankle extension, hip abduction, hip extension, knee extension, wrist extension, neck
flexion) was tested on a continuous scale (Newton). To compute a total score, values of each
muscle group were summated and this sum was then divided by eight.
Pain was measured using a Visual Analog Scale (VAS). A ten centimetres horizontal line
with the anchors ‘no pain’ (score of zero) and ‘worst pain’ (score of 100) was used [18].
Experimental procedures
Patients attended the university hospital Zurich on two occasions, to provide data to test con-
struct validity and reliability. During the first visit, patients’ demographic data were collected,
questionnaires (MAP, HAQ, SF36, pain) were completed and strength assessments (MMT8,
QMT, FI-2) were performed by one of two experienced physiotherapists. The latter had both
received instruction and training prior to the investigation. All patients, whose health status
remained unchanged, received a further copy of the MAP at their second visit. This was to pro-
vide data for reliability assessment. The time interval between the two visits ranged from one
to two weeks. Health status was assessed with the question: did your health status change since
the last visit to the hospital? The healthy control group individuals each received a copy of the
MAP by post at home and were requested to complete and return it via registered post-paid
mail envelope.
Data analysis
As the MAP uses an ordinal scale, nonparametric statistical analysis was used. Data are pre-
sented as median value with lower and upper quartiles and analyzed accordingly. Analysis was
performed using SPSS version 23.0.
Construct validity. Convergent validity was assessed by determining the Spearman corre-
lation coefficient for the relationship between the median scores of subscales and single items
of the German MAP and the HAQ, the physical and mental component score of the SF36, the
pain scale, the FI-2, the MMT8 and the QMT. A Spearman correlation coefficient of 0–0.25
was considered as no or very low correlation, 0.26–0.4 as low correlation, 0.41–0.69 as moder-
ate correlation, 0.70–0.89 as high and 0.90–1.0 as very high correlation [19].
The discriminative value of the MAP based on the gold standard (healthy by self-report)
was assessed by plotting the receiver operating characteristic (ROC) curve and by calculating
the area under the curve (AUC). The greater the area under the curve, the more accurate the
test is. We used the following classification proposed by Hosmer and Lemeshow: AUC = 0.5:
no discrimination, 0.7 to< 0.8: acceptable discrimination, 0.8 to 0.9: excellent discrimination
and> 0.9 outstanding discrimination [20].
Reliability. To determine reliability, the weighted kappa coefficients (KW) of subscales
and the single items were computed using GraphPad software (http://faculty.vassar.edu/
lowry/kappa.html). To interpret kappa values we applied the classification from Landis and
Koch (>0.8: almost perfect, 0.61–0.8: substantial, 0.41–0.6: moderate, 0.21–0.4: fair,<0.2
slight) [21]. The Mann-Whitney-U test was used to analyse systematic variations between test
and retest of the MAP. The level of significance was set to p�0.05.
Based on the evaluation of the original Swedish version, internal redundancy and internal
consistency were analyzed [8]. For internal redundancy, correlations between questions in the
subscales and for internal consistency correlations between individual items and their
Reliability and validity of the German-MAP
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subscales, after the actual item had been removed from the score, were computed. Spearman
correlation coefficients (rs)>0.90 were considered to indicate internal redundancy, and rs
<0.50 to indicate poor internal consistency [8].
Additionally, Cronbach‘s alpha coefficient was calculated to evaluate item fit within sub-
scales. Cronbach‘s Alpha values between 0.7 and 0.9 were considered as acceptable [22].
The study complied with the Helsinki Declaration and was approved by the local ethics
committee (registration no. 2014–0022 of the Cantonal Zurich Ethical Committee). All partici-
pants signed an informed consent.
Results
From the 76 patients invited to participate in this study, 28 declined because of “lack of time”,
“bad health condition” or “no interest”. Baseline characteristics of the 48 patients and 48
healthy controls are summarized in Table 1. Healthy controls had a significant lower BMI than
patients (median of 23 versus 26, p-value < 0.01). Score distribution of the subscales and single
items of the MAP are shown in Fig 1.
Construct validity
Convergent validity: The median of subscales and single items of the German MAP correlated
highly with the HAQ and the physical component score of the SF36; moderately with the total
scores of the FI-2, the QMT and the MMT8; and poorly with the mental component score of
the SF36 and with pain scale scoring (Table 2). Correlation coefficient values between the
MAP and the SF36 (PCS and MCS), the MMT8 and the FI-2 were all negative, as these are all
inverse relationships.
Discriminative validity: The ROC curves are shown in Fig 2. Three out of four subscales
and two out of four single items achieved acceptable AUC values (0.72–0.79). Subscale “per-
sonal care” and single questions “social” and “avoid over-exertion” indicated no acceptable
discrimination (AUC between 0.65 and 0.69), as illustrated in Table 3. Specificity and Sensitiv-
ity of possible cut-off values are presented in Table 4. For the subscales/single items a cutoff
level of two points and for the total median a cutoff value of 1.5 points leads to highest sensitiv-
ity. When considering the specificity, cutoff levels of 3 points for the subscales/single item val-
ues and 3.5 points for the total median values are therefore ideally required.
Reliability
Forty-four patients declared no change in their health status and were, therefore, included in
the reliability analysis. Weighted kappa coefficient values ranged from 0.65 to 0.71 for the
MAP subscales and 0.57 to 0.77 for the single items. No systematic differences between the
two test occasions were recorded (Table 5).
Internal redundancy: Spearman Correlation Coefficients between items in the subscale
“movement activities” (n: 9) varied between 0.29 and 0.81, in the subscale “moving around”
(n: 4) between 0.60 and 0.76, in the subscale “personal care” (n: 9) between 0.33 and 0.91, and
in the subscale “household” (n: 6) between 0.41 and 0.88. The two questions about “washing
and combing hair” were considered redundant (rs = 0.91).
Internal consistency: Correlations between individual items and their subscales after the
actual item had been removed from the score ranged from rs = 0.45 to 0.83 for the subscale
“movement activities”, rs = 0.70 to 0.78 for the subscale “moving around”, rs = 0.45 to 0.76 for
the subscale “personal care”, and rs = 0.48 to 0.87 for the subscale “household”. Three items
(standing for longer period, wiping yourself after bathroom, putting plates and glasses away)
indicate poor consistency.
Reliability and validity of the German-MAP
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Cronbach‘s alpha coefficient values for the four subscales ranged between 0.89 and 0.94
(movement: 0.94, moving around: 0.89, personal care: 0.94, household and 0.93).
Discussion
The German-MAP is the first disease-specific questionnaire for assessing limitations in activi-
ties of daily living in German-speaking patients with IM. This new German version of the
Table 1. Baseline characteristics.
patients with IM healthy controls
N:48 N: 48
Sex, n (%)
female 36 (75) 36 (75)
male 12 (25) 12 (25)
Age, in year
median (Q1-Q3) 60 (51–66) 60 (51–66)
BMI, in kg/cm2
median (Q1-Q3) 26 (22–29) 23 (20–25)
Diagnosis, n (%)
PM 17 (35.4)
DM 20 (41.7)
Associated 11 (22.9)
Disease stage, n (%)
acute 9 (18.8)
subacute 7 (14.6)
chronic 32 (66.7)
Time since diagnosis (months)
median (Q1-Q3) 18 (3–54)
HAQ, 0.00–3.00
median (Q1-Q3) 0.81 (0.13–1.38)
pain, VAS, 0–100
median (Q1-Q3) 14 (0–31)
SF36
PCS
median (Q1-Q3) 35 (30–49)
MCS
median (Q1-Q3) 51 (42–58)
FI-2
hip flexion
median (Q1-Q3) 13 (5–27)
shoulder flexion
median (Q1-Q3) 22 (10–55)
total score
median (Q1-Q3) 25 (16–46)
MMT8 total score
median (Q1-Q3) 71 (67–76)
QMT total score
median (Q1-Q3) 106 (91–137)
PM: polymyositis, DM: dermatomyositis, FI-2: Functional Index 2, HAQ: Health Assessment Questionnaire, PCS:
physical component score, MCS: mental component score, Q1: lower quartile, Q3: upper Quartile
https://doi.org/10.1371/journal.pone.0217173.t001
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MAP revealed acceptable construct validity: the majority of our hypotheses for discriminative
validity were confirmed. Good test retest reliability was recorded. Kappa values for all sub-
scales and three out of the four single items were substantial. The single question “avoid over-
exertion” just failed to reach substantial reliability. Cronbach‘s Alpha was acceptable for the
subscale “moving around”. For the three other subscales Cronbach‘s Alpha was higher than
expected.
Our results for the convergent validity are in line with previous studies. All three versions
of the MAP demonstrated higher correlations with a generic activity limitation questionnaire
(HAQ) than with muscle function assessment scores. The correlations between the two ques-
tionnaires (MAP and HAQ) were similar in all three countries (Spearman correlation coeffi-
cients ranging between 0.69 and 0.77). For muscle function, the correlations were more
heterogeneous across the different language versions. While the correlation coefficients of the
Fig 1. Score distribution of the subscales and single items of the Myositis Activity Profile in patients with IM and healthy controls, 1 = no difficulty,
7 = impossible to do.
https://doi.org/10.1371/journal.pone.0217173.g001
Table 2. Correlations between the total median score across the four subscales and the four single items of the
German Myositis Activity Profile (MAP) and other measures.
Measure German MAP
rs
CI
Health Questionnaires, N:46
HAQ 0.77 0.60–0.91
SF 36: PCS -0.78 -0.87 - -0.63
SF 36: MCS -0.28 -0.55–0.27
Muscle strength, N: 47
MMT8 -0.59 -0.76 - -0.34
QMT_total score -0.59 -0.76 - -0.34
Muscle endurance, N:45
FI-2 total score -0.64 -0.44 - -0.78
pain (during last week), N: 46 0.38 0.10–0.62
rs: Spearman correlation coefficient; MMT8: Manuel Muscle Test; FI-2: Functional Index 2; HAQ: Health
Assessment Questionnaire
https://doi.org/10.1371/journal.pone.0217173.t002
Reliability and validity of the German-MAP
PLOS ONE | https://doi.org/10.1371/journal.pone.0217173 June 3, 2019 7 / 13
MAP with muscle endurance in the Swedish and German cohorts were moderate (0.55 and
0.64), those in the English cohort were lower and poorer (between 0.29 and 0.47). Correlations
between the MAP and muscle strength were solely determined in the English and German
cohorts. Also for muscle strength, the English cohort showed lower correlations with the MAP
compared to the German cohort (0.35 versus 0.59, respectively). Reasons for these lower
Fig 2. Receiver operating characteristic (ROC) curve.
https://doi.org/10.1371/journal.pone.0217173.g002
Table 3. Area under the curve.
German MAP AUC CI
Subscales
Movement 0.78 0.68–0.87
Moving around 0.78 0.69–0.88
Personal Care 0.69 0.58–0.79
Domestic 0.79 0.70–0.88
Single Items
Social 0.65 0.54–0.76
Avoid overexertion 0.68 0.57–0.79
Work/school 0.72 0.62–0.82
Recreational 0.75 0.66–0.85
MAP: Myositis Activity Profile; AUC: Area under the Curve, CI: Confidence Interval
https://doi.org/10.1371/journal.pone.0217173.t003
Reliability and validity of the German-MAP
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correlations between the MAP and muscle function in the English cohort are unclear. The sub-
ject sample in the German cohort is slightly older than the two other cohorts (60 years versus
55 and 52 years), however, the Swedish cohort has the highest MAP scores. Concerning muscle
Table 4. Sensitivity, specifity at different cut-offs.
German MAP cut-off Sensitivity Specificity
Subscales
Movement 2.00 68.75 75.00
3.00 52.08 95.83
Moving around 2.00 64.58 87.50
3.00 50.00 95.83
Personal care 2.00 45.83 89.58
3.00 33.33 95.83
Household 2.00 68.75 83.33
3.00 43.75 95.83
Single Items
Social 2.00 41.67 83.33
3.00 31.25 97.92
Avoid overexertion 2.00 75.00 50.00
3.00 50.00 75.00
Work/school 2.00 68.75 64.58
3.00 43.75 89.58
Recreational 2.00 68.75 75.00
3.00 54.17 87.50
Total median 1.50 70.83 81.25
2.00 66.67 85.42
0.50 47.92 93.75
3.00 41.67 95.83
3.50 22.92 97.92
4.00 18.75 97.92
4.50 6.25 97.92
MAP: Myositis Activity Profile
https://doi.org/10.1371/journal.pone.0217173.t004
Table 5. Test retest reliability of subscales and single items of the German MAP.
MAP Test
Median
(Q1-Q3)
N: 44
Retest
Median
(Q1-Q3)
N: 44
Kw 95%CI Sign Test
p
Subscales
Movement 3.3 (1.0–3.0) 2.0 (1.0–4.0) 0.67 0.54–0.81 0.34
Moving around 2.5 (1.0–4.0) 2.0 (1.0–3.0) 0.65 0.54–0.75 0.09
Personal Care 1.0 (1.0–3.0) 1.0 (1.0–3.0) 0.7 0.55–0.84 0.31
Domestic 2.0 (1.0–3.8) 3.0 (1.0–4.0) 0.71 0.61–0.82 0.78
Single Items
Social 1.0 (1.0–3.0) 1.0 (1.0–3.0) 0.77 0.63–0.92 0.57
Avoid overexertion 2.5 (1.3–4.0) 2.5 (1.0–4.0) 0.57 0.41–0.74 0.35
Work/school 2.0 (1.0–3.8) 2.5 (1.0–4.0) 0.67 0.53–0.81 0.2
Recreational 3.0 (1.0–4.0) 3.0 (1.0–4.0) 0.71 0.55–0.87 0.27
MAP: Myositis Activity Profile; Q1: lower quartile, Q3: upper Quartile; KW: weighted kappa coefficient; CI: Confidence Interval
https://doi.org/10.1371/journal.pone.0217173.t005
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strength, the English and German cohorts were comparable [8, 9]. Future studies with larger
samples may shed greater light on this issue. The current correlation is an estimate and only
with increasing sample size can we hope to progress towards a more stable and representative
value [23].
In general, muscle strength and muscle endurance values correlated only moderately with
the MAP. This emphasizes the importance of using Health-Related Patient-Reported Out-
comes as well as assessments of physical performance. This was the first time that the MAP has
been compared with the SF36 and with pain scores. The higher correlation found with the
physical component summary than with the mental component summary of the SF36 supports
the notion that the MAP does measure activity limitation. Although pain is an important out-
come measure in patients with IM, it did not seem to affect activity limitation in our sample.
The reason for this could be that our sample reported rather low pain levels on the VAS.
The gender and age matched control group indicated lower scores in all subscales/single
items when compared with patients (Fig 1). Nevertheless, three items did not reach acceptable
discriminative validity. One of these items was “avoid overexertion”. This is the only item that
has a median higher than one in the healthy control group. Avoid overexertion does not seem
to be an illness-related problem, but rather an individual or age-related challenge. Although
our controls had to be healthy (by self-report), it is not impossible that they suffered from age-
related problems such as physical deconditioning or arthritis, especially as half of our sample
was older than 60. The remaining two items with low discriminative validity were “personal
care” and “social”. These were the two items with the lowest rating in our patients group
(median of one) as well as in the American and Swedish cohort [8, 9]. Patients seem to manage
their personal care despite physical limitations. Perhaps this is because they have developed
good coping strategies and/or have adapted their personal environments in such a way that
they can live independently. For example, one woman in our sample told us that because she
had problems drying her long hair she had it cut short. The item “social” is defined as “to keep
in touch with and meeting friends or relatives”. It appears that, despite their physical limita-
tions, the social lives of people who have IM are not strongly affected.
The level at which the cut-off value should be set for discrimination between patients and
healthy persons is not obvious. When considering only the sensitivity, the cutoff should be at 2
points, but when considering the specificity, the cutoff would be at 3 points. Therefore, it is ques-
tionable if the MAP should be used as a screening tool. In actuality, the MAP was developed for
assessing activity limitation among patients with IM [8], rather than a discriminatory tool.
Assessment items “washing hair” and “combing hair” both demonstrated high internal
redundancy. In fact, these two activities are very similar. Because the item “washing hair” is
rated lower, it could potentially be excluded from the questionnaire. In three out of the four
subscales, one item indicated poor internal consistency: “standing for long period” from the
subscale “movement”, “wiping yourself after bathroom” from the subscale “personal care” and
“putting plates and glasses away” from the subscale “household”. For the items “standing for a
longer period” and “putting plates and glasses away” it is questionable whether they belong to
their current subscales. “Standing for a longer period” is the only item in the subscale “move-
ment” that is a static rather than a dynamic activity. All the other activities are dynamic ones.
This may be a reason why this item does not appear to fit this subscale. In the subscale “house-
hold” all activities other than “putting plates and glasses away” demand predominantly lower
rather than upper extremity performance, or else focus on the body as a whole. Because the
activity involves putting plates and glasses away in the top of a cupboard, other attributes such
as adequate upper limb strength and range of motion are required.
As might be anticipated, our study had certain strengths as well as limitations. One strength
is that we were almost able to recruit the COSMIN initiative minimum recommended number
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of 50 participants [24], despite IM being a relatively rare disease. Sixty-three percent of the
patients, who visited our department and who were informed about this study, satisfied our
selection criteria and agreed to participate. Another strength is the inclusion of a healthy con-
trol group. This is the first time that the MAP has been compared across both patients and
healthy individuals. A limitation may be that the healthy controls and patients were only
matched by age and gender and not by other possibly biasing factors; e.g. their physical activity
level. The healthy control group had a significant lower BMI than patients; this may be an indi-
cation that the former were more active than the latter. Therefore, we do not know if healthy
controls have fewer activity limitations than patients because they are more active, or if they
are more active because they do not have muscle symptoms. To definitively exclude the influ-
ence of physical activity, its level across both patients and healthy controls should ideally be
controlled for. Another possible limitation is that the study was performed in the German
speaking part of Switzerland. To avoid a Swiss bias to the translation, one translator had a Ger-
man background. Nevertheless, participants from other German speaking countries, such as
Germany or Austria, might have judged certain items differently. A further limitation of our
study is that we could not conduct a factor analysis. For this analytical approach, a minimum
of four to ten cases per item is required [22], a participant number that was beyond our proj-
ect’s capacity. Based on the encouraging findings of our study an international multi-center
study might be considered to assess the replicability of our findings.
Although the MAP showed acceptable validity, there are some ambiguities concerning the
structure and scoring of this questionnaire, which should also be considered in any future studies.
The score of a subscale is the median of the scores from all items within it. Because the median is
unaffected by extreme scores in such a scoring strategy, easier items have greater influence in the
scoring of a subscale. This leads to the fact that all patients, who have no difficulty in more than
fifty percent of the activities of a subscale end up having the same score, independently of the
scoring of the other items. This scoring approach may lead to underestimation of the activity lim-
itation of participants. Another pitfall of the MAP could be the fact that patients have to weight
their difficulties against their needs when answering questions. Patients‘ abilities to reliably weight
both the importance and the difficulty of their own performance has yet to be investigated [8].
This initial validation of the German version of the MAP revealed acceptable validity and
good reliability for assessing activity limitation among German speaking Swiss patients with
IM. Further validation is required to fully verify these results, using German and/or Austrian
participant groups. Furthermore, structure and scoring as well as responsiveness of the MAP
should ideally be evaluated in a larger multicenter study.
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